Year : 2021 | Volume
: 7 | Issue : 3 | Page : 135--136
What's new in academic international medicine? Redefining our purpose, setting new goals, and refocusing our efforts
Taryn Clark1, Stanislaw P Stawicki2,
1 Department of Emergency Medicine, International Division, SUNY Downstate Medical Center/Kings County Hospital Center, Brooklyn, NY; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
2 Department of Research and Innovation, St. Luke's University Health Network, Bethlehem, Pennsylvania, USA
Dr. Taryn Clark
Department of Emergency Medicine, International Division, SUNY Downstate Medical Center/Kings County Hospital Center, Brooklyn, NY; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
|How to cite this article:|
Clark T, Stawicki SP. What's new in academic international medicine? Redefining our purpose, setting new goals, and refocusing our efforts.Int J Acad Med 2021;7:135-136
|How to cite this URL:|
Clark T, Stawicki SP. What's new in academic international medicine? Redefining our purpose, setting new goals, and refocusing our efforts. Int J Acad Med [serial online] 2021 [cited 2021 Nov 27 ];7:135-136
Available from: https://www.ijam-web.org/text.asp?2021/7/3/135/326812
It has been a rewarding 7 years since the inaugural issue of the International Journal of Academic Medicine (IJAM). A total of 20 issues with more than 330 articles have been published and IJAM's scientific content has been accessed more than 1 million times, with numerous associated citations and steadily growing impact. In keeping with this impressive record, our team continues to push forward with new initiatives and important updates.
Over the past few months, we spent significant time and effort to ensure that IJAM remains highly relevant within its intended niche and that it further refines its focus to even better reflect its mission and vision – A journal with truly international scope, actively focused on promoting diversity, equity, and inclusion (DEI) worldwide. A large component of this transformational change was to increase the diversity of our Editorial Board. As a result, our newly updated team includes much greater representation from across the globe, with a significant increase in the proportion of Section Editors from Africa, South America, Europe, and East Asia.
How does IJAM and its primary sponsoring organization, The American College of Academic International Medicine (ACAIM), fulfill their common mission of promoting DEI in the field of Academic International Medicine? In addition to advocating for DEI at the organizational level, ACAIM is also involved in several strategic collaborations that are essential in this context. These include our ongoing joint activities with the Novick Cardiac Alliance, Women in Medicine, the American Academy for Emergency Medicine, and the Kiran and Pallavi Patel Family Foundation, among others. We also actively support and promote the publication of content that is directly relevant to DEI – and have been proactively doing so since the Journal's inception.
The significant growth of IJAM over the years is also evident when one considers that the Journal started with a single issue in December of 2015, progressed to two issues per year in 2016 and 2017, expanded to three issues annually in 2018 and 2019, with quarterly publication frequency starting in 2020. In terms of overall journal quality, our stringent peer-review process resulted in a 2020 acceptance rate of approximately 20%, with nearly 500 registered authors and 330 registered peer reviewers. Moreover, we remained true to our promise to publish “at cost” with some of the lowest open-access publication fees in the industry. Whenever possible, we move to waive publication fees, especially for authors from low- and middle-income countries, as well as for trainees who submit their work to IJAM.
One of the greatest transformations in our quest for improving the overall quality of published articles was the implementation of mandatory author compliance with established EQUATOR Network guidelines. For more than 2 years, every single article submitted to IJAM must comply with appropriate EQUATOR guidelines (e.g. CARE paradigm for case reports) before it is considered suitable for peer review. Strict ethical guidelines followed by the IJAM Editorial Office now include hardwired conflict of interest rules, patient consent declarations for case reports, applicable clinical trials registrations, and Institutional Review Board/Ethics review information included in every manuscript.
In the coming years, we aim to increase our manuscript representation from traditionally under-published communities and countries. Through outreach to academic institutions and individuals, we will encourage submissions from low- and middle-income countries as well as continue to waive publication fees, as justified by circumstances and resources, for manuscripts accepted after peer review. We will continue to recruit and actively support qualified, diverse peer reviewers and offer a reviewer-in-training pathway for those who are new to the reviewing process. Through this pathway, we aim to increase the depth and breadth of representation within our reviewer ranks. We will use our editorial section to provide opportunities for diverse authors to address the Academic International Medicine community and amplify issues of concern.
Now in the depth of the coronavirus disease 2019 (COVID-19) pandemic, more than ever, we have seen that our world is a true global community. Our health problems cannot be solved in a vacuum. Academic International Medicine as a field aims to advance best practices in medicine in an ethical, sustainable, and equitable manner. International and global coordination is critical to this effort and IJAM remains dedicated to providing a forum for these ongoing discussions and exchanges of information. Finally, as the official ACAIM journal, IJAM will continue to disseminate new research, recommended guidelines, and promote policy in the area of Academic International Medicine.
On behalf of the entire Editorial Board, we welcome your feedback, participation and collaboration. Please reach out with any questions or constructive criticism. We look forward to working together to make IJAM the premier worldwide destination for publications in Academic International Medicine.
Ethical conduct of research
The authors declare that this Editorial does not require Institutional Review Board/Ethics review or approval.
Conflicts of interest
Both Dr. Clark and Dr. Stawicki are Principal Editors of IJAM.